Formoterol is a long-acting beta-2 agonist (LABA) for airway obstruction. It facilitates bronchodilation by stimulating beta-2 receptors in the bronchial smooth muscle, leading to the sustained relaxation of airway constrictions.
Formoterol belongs to the long-acting beta-agonist (LABA) class of bronchodilators. It is designed to relax the smooth muscles around the airways, helping them stay open for an extended period after each dose. The compound is often combined with an inhaled corticosteroid to address both airway inflammation and constriction. In Singapore, it appears in several inhalation products that are regulated by the Health Sciences Authority (HSA).
Formoterol is present in a range of inhalation devices marketed locally, such as Symbicort Powder, Budesonide Formoterol Inhaler, and Budesonide Formoterol Rotacaps. These products may be supplied as dry-powder inhalers, metered-dose inhalers, or capsule-based devices. While brand names differ, the active component remains the same, and generic equivalents are subject to the same HSA standards for quality and safety.
These applications are generally directed at adults and adolescents who require ongoing control of airway tone, rather than immediate relief of an acute attack.
When inhaled, formoterol reaches the bronchial smooth muscle and stimulates receptors that cause relaxation. This action widens the airway lumen, allowing more air to flow with each breath. Because the effect can last up to 12 hours, it provides a steady level of bronchodilation without the need for frequent dosing.
Formoterol-containing inhalers should be stored in a cool, dry place, away from direct sunlight. Devices that rely on propellants or capsules must be kept upright to maintain dose integrity. Treatment duration varies: some patients use the medication for short-term control, while others incorporate it into long-term management plans. For precise dosing intervals and length of therapy, consult the labeling of the individual product.
This article offers an educational overview of formoterol as an active substance and does not constitute medical advice. Individual products containing this compound, such as the listed inhalers, may differ in strength, formulation, and usage directions. The author assumes no liability for clinical decisions based on this information. Readers should review the labeling of their specific medication and seek guidance from a qualified healthcare professional for personalized recommendations.
